<DOC>
	<DOCNO>NCT01688414</DOCNO>
	<brief_summary>This pilot clinical trial study image surgery diagnose patient prostate , bladder , kidney cancer . New diagnostic imaging procedure , may find prostate , bladder , kidney cancer</brief_summary>
	<brief_title>Imaging During Surgery Diagnosing Patients With Prostate , Bladder , Kidney Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . The primary objective pilot study assess ability fluorescent image photoacoustic imaging ( PAI ) clinical set distinguish benign malignant tissue . SECONDARY OBJECTIVES : I . To qualitatively determine possible benefit PAI fluorescent image traditional white light image . OUTLINE : Patients undergo fluorescence image PAI robot assist laparoscopic surgery .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>Patients must pathologic confirmation prostate cancer , bladder cancer , kidney cancer base previous biopsy procedure OR strong concern kidney malignancy base compute tomography ( CT ) magnetic resonance imaging ( MRI ) image Ability understand willingness sign write informed consent document Patients surgical history anatomic variant would preclude robot assist laparoscopic approach surgery ( i.e . history ventral hernia repair mesh ) Patients medical comorbidities tolerate laparoscopic surgery secondary intraabdominal carbon dioxide insufflation Patients document allergy adverse drug reaction indocyanine green baseline serum creatinine great 1.5 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>